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Kidney disease is associated with increased cardiovascular
morbidity, but underlying mechanisms are poorly
understood. We tested the hypothesis that chronic renal
insufficiency impairs angioadaptation in a rat model of
hindlimb ischemia. Twenty male Sprague–Dawley rats (8
weeks old) underwent subtotal nephrectomy (5/6SNX) or
sham surgery (each n¼ 10). Ten weeks later, unilateral
hindlimb ischemia was induced in all animals. Hindlimb
perfusion was assessed by laser Doppler perfusion imaging
and fluorescent microsphere injection studies 2 weeks after
surgery. Ischemia-induced angiogenesis was measured by
analyzing capillary density using CD31 immunofluorescence.
Expression of vascular endothelial growth factor (VEGF), its
receptors (VEGFRs) and inducible as well as endothelial nitric
oxide (NO) synthase was measured by real-time reverse
transcription-polymerase chain reaction. Laser Doppler
hindpaw perfusion was significantly reduced in 5/6SNX
compared to sham-operated animals. Impaired hindlimb
re-perfusion in 5/6SNX vs control rats was confirmed by
fluorescent microsphere injection studies (relative perfusion
of ischemic vs non-ischemic limb: 68.976.4 vs 92.473.6%,
P¼ 0.005). Ischemic skeletal muscle neovascularization
increased to a greater extent in sham-operated compared to
5/6SNX rats (6978 vs 2977%, Po0.05). VEGF and VEGFR-1/2
mRNA expression increased in ischemic hindlimbs of control
rats, whereas no change or a decrease was observed in
5/6SNX. In contrast, inducible and endothelial NO synthase
expression did not significantly differ between sham and
5/6SNX rats. Chronic renal insufficiency impairs angiogenesis
and limb perfusion in a rat hindlimb ischemia model.
Impaired angioadaptation may contribute to the poor
prognosis of patients with renal failure suffering from
peripheral arterial disease.
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Despite promising novel therapeutic strategies, morbidity
and mortality of patients with end-stage renal disease has not
markedly improved throughout the last decade. The major
cause of death in end-stage renal disease are cardiovascular
events, which result to a large degree from accelerated
atherosclerosis under uremic conditions.1–4
Little is known as to whether angioadaptive processes are
altered in renal disease. Postnatal blood vessel formation
occurs via three distinct mechanisms designated as vasculo-
genesis, angiogenesis, or arteriogenesis. Vasculogenesis de-
scribes the formation of blood vessels from circulating
endothelial progenitor cells (EPCs) that home and differ-
entiate at sites of neovascularization, angiogenesis represents
capillary growth through sprouting or intussusception of
capillaries, whereas arteriogenesis refers to collateral growth,
that is, the growth and maturation of a pre-existing arteriole
into a conductance vessel.5 Kidney failure is associated with
decreased capillary density in the myocardium of humans
with end-stage renal disease or in subtotally nephrectomized
rats.6,7 Interestingly, the same authors who described this
observation reported that the capillarization of skeletal
muscle was not diminished in a rat remnant kidney model.6
Other investigators, however, did report decreased capillary
density of both locomotor and non-locomotor muscles in
patients with renal failure.8,9 Whereas these data indicate
altered capillary architecture in renal disease, it remains
unclear whether this is because of capillary rarefication or
impaired neovascularization. The aim of the present study
was to investigate the impact of chronic renal failure (surgical
ablation of 5/6 of renal mass) on ischemia-induced
angiogenesis and hindlimb re-perfusion in a rat model of
hindlimb ischemia. We hypothesized that uremia impairs
angioadaptation in response to ischemia.
RESULTS
Physiological and biochemical parameters
Twelve weeks after 5/6 nephrectomy, there were no
differences in body weight (442718 vs 45479) or mean
arterial blood pressure (10675 vs 11075 mm Hg) between
control and subtotally nephrectomized animals. Serum
creatinine and urea were markedly elevated in nephrecto-
mized rats (Table 1). Uremic animals developed some degree
of proteinuria, but no metabolic acidosis as indicated by
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normal pH and bicarbonate. There were only mild, yet
significant differences in hemoglobin and hematocrit, and a
trend towards lower serum erythropoietin levels in subtotally
nephrectomized rats (Table 1). As expected, plasma levels of
asymmetrical dimethylarginine (ADMA), an endogenous
inhibitor of nitric oxide (NO) synthase, were significantly
elevated in uremic animals, whereas plasma as well as urinary
nitrate/nitrite concentration were similar between control
and uremic rats (Table 1). Interestingly, plasma levels of
vascular endothelial growth factor (VEGF) levels were B2-
fold higher in uremic rats and closely correlated with serum
creatinine levels (r¼ 0.80, P¼ 0.0007; Table 1).
During 24-h urine collection in metabolic cages, ne-
phrectomized rats lost more weight (6.171.7 vs
14.372.8 g, P¼ 0.023), consumed more water (26.071.8
vs 37.174.2 ml, P¼ 0.028), and voided more urine
(17.571.2 vs 31.873.5 ml, P¼ 0.001), whereas food intake
was similar (15.271.5 vs 13.071.0 g, P¼NS).
Skeletal muscle histomorphology
Histomorphology of hematoxylin/eosin-stained cross-sec-
tions of non-ischemic and ischemic hindlimbs did not differ
between treatment groups. Based on the number of myocytes
per field, mild muscle atrophy was noted in ischemic
hindlimbs (M. gastrocnemius, sham vs 5/6: 13.676.1 vs
16.076.5%, P¼NS; M. soleus, sham vs 5/6: 8.279.1 vs
13.273.8%, P¼NS). Contiguous areas of atrophied myo-
cytes with centralized nuclei indicative of ischemic tissue
undergoing regeneration were seen rarely, and at a similar
frequency in sham-treated and nephrectomized rats. These
regions spanned only very small proportions of the entire
cross-sectional area and were largely devoid of inflammatory
infiltrates or myocyte necrosis. Otherwise, the predominant
finding within ischemic muscle sections was the scarce
presence of single atrophied myocytes (Figure 1).
Media thickness of collateral vessels of the ischemic
hindlimb increased by 3576% in uremic rats, compared to
the non-ischemic limb, and to a similar degree in non-uremic
animals (3273%). A minimal degree of intimal thickening
was occasionally noted (Figure 1): Intima–media ratios
within ischemic hindlimbs did not differ between control
and uremic rats (0.07270.020 vs 0.06670.017, P¼NS).
Calcifications were not observed.
Capillary density
Capillary density of non-ischemic hindlimbs was similar
between sham-treated and nephrectomized rats (Table 2). In
Table 1 | Biochemical parameters
Variable Sham 5/6NX P-value
Creatinine (mg/dl) 0.5370.07 1.2270.15 0.001
Urea (mg/dl) 7578 131712 0.001
UAE (mg/24 h) 0.570.1 19.777.2 0.016
UAE (mg/g creatinine) 3377 14267528 0.017
Phosphate (mmol/l) 2.770.13 3.470.19 0.009
Calcium (mmol/l) 2.670.16 2.470.19 NS
Hemoglobin (g/dl) 15.870.5 14.270.3 0.020
Hematocrit (%) 48.571.6 42.871.0 0.007
Erythropoietin (mIU/ml) 30.977.6 13.474.0 NS
Plasma ADMA (mM) 0.6670.03 0.8870.08 0.024
Plasma NOx (mM) 8.471.6 5.970.7 NS
Urinary NOx (mM) 19.272.4 13.572.6 NS
Plasma VEGF (pg/ml) 77712 134719 0.020
ADMA, asymmetrical dimethylarginine; NOx, urinary nitrate/nitrite; UAE, urinary
albumin excretion; VEGF, vascular endothelial growth factor.
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Figure 1 | Histomorphology of skeletal muscle and blood vessels.
(a) Skeletal muscle histomorphology (M. soleus) 2 weeks after
induction of limb ischemia. Arrows indicate atrophied myocytes with
centralized nuclei (original magnification,  20, hematoxylin and
eosin (H&E) staining). (b) Analysis of collateral vessels by light
microscopy: collateral vessel within ischemic skeletal muscle (M.
gracilis) of a sham-treated rat. Blood vessels are surrounded by an
inflammatory infiltrate and myocytes with centralized nuclei (original
magnification,  20, H&E staining). (c) Analysis of collateral vessels by
fluorescence microscopy: collateral vessel within ischemic skeletal
muscle (M. gracilis) of a sham-treated rat; (red) CD31 and (green)
a-smooth muscle actin (original magnification,  40).
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contrast, the increase in capillary density (capillaries/myo-
cyte) as well as capillary area (expressed as capillary area/100
myocytes) relative to the non-ischemic hindlimb was
approximately twofold higher in sham-operated, opposed
to nephrectomized rats (Figures 2 and 3). The angiogenic
response was more pronounced if capillary area was analyzed
(Figure 2).
Laser Doppler hindlimb perfusion
Hindlimb perfusion as assessed by laser Doppler perfusion
imaging (ratio ischemic/non-ischemic limb) decreased to a
similar extent in sham vs nephrectomized rats 1 day after
induction of hindlimb ischemia with perfusion deficits being
most prominent within the hindpaw (Figure 4). After 2
weeks, hindpaw perfusion ratio as well as the increase after
induction of ischemia was significantly greater in sham vs
nephrectomized rats (D ratio days 1–14: 0.4070.06 vs
0.1770.07, P¼ 0.021; Figure 4).
Microsphere analysis
Based on normalized fluorescent signal intensities, hindlimb
perfusion was almost fully restored in sham-treated animals
after 14 days. Relative perfusion of ischemic vs non-ischemic
hindlimb was 92.473.6% (95% confidence interval
84.1–100.6%). In contrast, hindlimb re-perfusion was mark-
edly reduced in rats with chronic renal failure in which
relative perfusion was only 68.976.4% (95% confidence
interval 54.4–83.4%; sham vs 5/6, P¼ 0.005). There was an
inverse correlation between relative perfusion and urinary
albumin excretion (r¼0.70, P¼ 0.001) and serum creati-
nine (r¼0.54, P¼ 0.022); thus, the greater the proteinuria
or creatinine, the worse was hindlimb re-perfusion.
Expression of VEGF, VEGFRs, and NO synthase isoforms
In sham-treated rats VEGF mRNA increased, whereas no
significant change was observed in nephrectomized rats
(Figure 5). Relative to the non-ischemic hindlimb VEGF,
mRNA expression increased by 36.7711.6% in sham-treated
rats, whereas it decreased by 2.379.0% in 5/6 rats
(P¼ 0.029). Expression of VEGF receptor 1 (VEGFR-1)
mRNA was similar in non-ischemic hindlimbs, whereas
expression in ischemic hindlimbs was significantly greater in
sham vs 5/6 rats (Figure 5). Relative to the non-ischemic
hindlimb VEGFR-1, mRNA expression increased by
21.8714.3% in sham-treated rats, whereas it decreased by
22.9712.3% in 5/6 rats (P¼ 0.04). Expression of VEGF
receptor 2 (VEGFR-2) mRNA was similar in non-ischemic
and ischemic hindlimbs of sham- and 5/6-treated rats and the
relative change tended to be greater in sham vs 5/6 rats
(55.9734.0 vs 24.0711.1%, P¼ 0.056; Figure 5).
Despite marked differences in capillary density, ischemic
endothelial NO synthase mRNA expression did not sig-
nificantly differ between sham and 5/6 rats (10477116 vs
8127200 relative copies, P¼NS). Similarly, inducible NO
synthase mRNA expression did not differ between treatment
groups (4377151 vs 4567144 relative copies, P¼NS).
Table 2 | Capillary density of non-ischemic and ischemic calf
muscles
Sham 5/6NX
P-value sham
vs 5/6NX
Non-ischemic
M. gastrocnemius
Capillaries/myocyte 1.4670.06 1.5870.09 NS
Capillary area/100
myocytes (%)
0.8970.04 1.0170.08 NS
M. soleus
Capillaries/myocyte 1.5270.09 1.5870.08 NS
Capillary area/100
myocytes (%)
1.0270.10 1.0070.04 NS
Ischemic
M. gastrocnemius
Capillaries/myocyte 2.4370.12*** 2.0570.14** o0.05
Capillary area/100
myocytes (%)
1.8670.14*** 1.5370.07*** o0.05
M. soleus
Capillaries/myocyte 2.4770.14*** 1.9770.13* o0.05
Capillary area/100
myocytes (%)
2.1070.10*** 1.3970.07** o0.001
*Po0.05; **Po0.01; ***Po0.001 vs non-ischemic.
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Figure 2 | Neovascularization of skeletal muscle. (a) Percent
increase of capillary density (capillaries/myocyte) in ischemic
hindlimbs vs non-ischemic hindlimbs 14 days after induction of
ischemia. Angiogenesis is significantly impaired in rats that
underwent renal mass reduction. (b) Percent increase of capillary
area (capillary area/100 myocytes) in ischemic hindlimbs vs
non-ischemic hindlimbs 14 days after induction of ischemia.
*Po0.05; **Po0.01; ***Po0.001.
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DISCUSSION
In the present study, we show that uremia impairs ischemia-
induced angiogenesis and limb re-perfusion in a rat model of
hindlimb ischemia. Angiogenesis in response to limb ischemia
was less pronounced in subtotally nephrectomized compared
to sham-treated rats. In addition, hindlimb re-perfusion as
assessed by laser Doppler flowmetry and fluorescent micro-
sphere injection studies was markedly impaired in rats
undergoing renal mass reduction. These findings indicate an
impaired angioadaptation in chronic kidney failure.
Chronic kidney disease has been recognized as a strong
risk factor for vascular events, which are the major cause of
mortality in these patients.10–12 This relationship does
include a markedly increased risk for developing clinically
apparent peripheral vascular disease,2,10 and a poorer
outcome from peripheral vascular disease.1 Despite these
observations, the impact of renal disease on neovasculariza-
tion of the skeletal muscle circulation has received little
attention. To date, investigations have largely focused on
vascular remodeling and the specific role of angiogenic
growth factors within the remnant kidney itself. Thus,
angiogenesis in the remnant kidney indexed as glomerular
as well as peritubular capillary density is impaired in rats
undergoing 5/6 renal ablation.13 Moreover, subcutaneous
injections of VEGF121 reduce renal fibrosis and stabilize renal
function in this animal model through enhanced endothelial
cell proliferation and decreased peritubular capillary rarefica-
tion.14 In line with these observations, we could demonstrate
that chronic renal failure impairs expression of VEGF and
VEGFRs in ischemic but not in non-ischemic hindlimbs, and
this was associated with impaired angiogenesis. Local VEGF
expression plays a critical role in ischemia-induced angiogen-
esis and is triggered by hypoxia and under the control of
transcriptional factors belonging to the hypoxia-inducible
factor family.5 However, plasma levels of VEGF were elevated
in rats with renal ablation despite reduced VEGF mRNA
expression in ischemic hindlimbs. This finding is in line with
recent observations made by other investigators.15,16 It
remains unclear whether elevated immunoreactive VEGF
levels represent ‘true’ VEGF, or metabolites of the peptide.
Nevertheless, these data do not support the idea that a
general deficiency of VEGF explains the impaired angiogen-
esis in skeletal muscle.
The effects of chronic renal failure were not restricted to
ischemia-induced angiogenesis only but arteriogenesis was
probably attenuated as well. This notion is supported by the
impaired hindlimb re-perfusion assessed with fluorescent
microsphere technique. The growth of pre-existing arterioles
into collateral conduits is an efficient way to compensate for
reduced tissue perfusion in addition to sprouting of
capillaries. Microsphere analyses in this study indicate that
2 weeks after induction of limb, ischemia perfusion is almost
fully restored in sham-treated rats, whereas it is considerably
reduced in subtotally nephrectomized rats. In contrast, laser
Doppler studies only revealed significant perfusion deficits in
hindpaw, yet not hindlimb perfusion in uremic rats. This
discrepancy is in agreement with observations made by other
investigators showing decreased limb perfusion using micro-
sphere technique despite normalization of laser Doppler
perfusion.17 Although widely applied, we consider laser
a b c
Figure 3 | Representative images of capillary density in non-ischemic and ischemic calf muscle sections. Top panel: CD31
immunofluorescence (capillaries in red); bottom panel: double fluorescent staining for (red) CD31 and (blue) laminin. (a) Capillary density
of non-ischemic muscle of a rat with renal mass reduction. (b) Capillary density of ischemic muscle of a rat with renal mass reduction.
(c) Capillary density of ischemic muscle of a sham-treated rat. Hindlimb ischemia causes neovascularization (angiogenesis) in both treatment
groups with a greater response in rats without renal impairment.
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Doppler flowmetry as being of limited value owing to the low
penetration depth of the laser light.
Unlike angiogenesis, arteriogenesis occurs independent of
hypoxia and is mainly driven by inflammation and
hemodynamic forces such as changes in shear stress.18 Thus,
occlusion of an artery increases flow in the proximal feeding
arteries that in turn elevates shear stress in pre-existing
arteriolar blood vessels that bypass the occlusion. An increase
in flow and shear stress is sensed by the endothelium and
causes vasodilation via NO. Uremia attenuates NO-depen-
dent flow-mediated vasodilation as indicated by in vitro
studies in rat isolated skeletal muscle arterioles.19 Further-
more, in vivo studies in humans confirm an impaired
endothelium-dependent NO-mediated vasodilation in the
forearm vasculature of hemodialysis patients.20,21
One explanation for decreased NO bioavailability may be
elevated levels of the endogenous NO synthase inhibitor ADMA
in renal failure.22 In a recent prospective clinical trial, ADMA
levels emerged as a strong and independent predictor of overall
mortality in patients with chronic renal failure.23 In our present
study, renal failure was associated with significant elevations in
systemic ADMA levels. We did not observe decreased nitrate/
nitrite levels or an altered expression of endothelial NO
synthase in rats with chronic renal failure, but further
experiments will be required to define the possible role of
altered NO bioavailability. In any case, a role of elevated ADMA
appears conceivable because this molecule impairs angiogenesis
and arteriogenesis in a murine hindlimb ischemia model.24
However, several other perturbations present in renal
failure may also play a role. Increased oxidative stress could
affect arterial vessels.25 Calcification of arteries in chronic
renal failure may result from abnormalities of calcium and
phosphorus metabolism,26 or from the lack of inhibitors of
calcification,26 for example, serum fetuin-A.27 We did not
observe calcifications of collateral vessels, which may be
because of the duration or extent of chronic renal failure, or
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Figure 4 | (a) Laser Doppler perfusion imaging. Flux images of a sham (top panel) and nephrectomized (bottom panel) rat before surgery
and on days 1 and 14 post-surgery. Hindpaw re-perfusion is impaired in red rectangles subtotally nephrectomized rats (red rectangle).
(b) LDPI ratio (ischemic/non-ischemic hindpaw). After induction of hindlimb ischemia, there was a dramatic reduction in hindpaw perfusion
in both sham as well as nephrectomized rats. At 2 weeks after surgery, perfusion ratio was significantly lower in rats with renal mass
reduction as opposed to sham-treated animals. *Po0.05.
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to the relatively mild elevation of phosphorus levels in our
animals. A decreased number of circulating EPCs, which may
contribute to vasculogenesis, may also contribute to the
impaired angiogenesis observed in our study. Circulating
EPCs are stimulated by erythropoietin,28 which tended to be
lower in our uremic rats. Further, EPCs are markedly reduced
in the peripheral blood of patients with advanced renal
failure, compared with healthy subjects.28–31 However, the
precise role of EPCs in blood vessel generation is still
controversial.15,32 Thus, Herbrig et al. recently reported
an increased total number but an impaired migratory
activity and adhesion of EPCs in patients undergoing
hemodialysis.32
In conclusion, chronic renal failure impairs ischemia-
induced angiogenesis and hindlimb re-perfusion in a rat
model of hindlimb ischemia. Impaired angiogenesis may
contribute to the burden of peripheral arterial disease in
patients with renal failure. Our results point to a possible role
of increased ADMA and/or decreased local expression of
VEGF and its receptors for impaired angiogenesis, but the
identification of the precise mechanisms involved will require
further studies.
MATERIALS AND METHODS
Animals
All experiments were performed in male Sprague–Dawley rats
(Charles River, Sulzfeld, Germany) kept in a temperature-controlled
animal facility on a 12-h light/dark cycle, with tap water and rodent
chow ad libitum. The study protocol was approved by the animal
research ethics committee of the local government (Bezirksregierung
Mittelfranken, AZ 621-2531.31-21/04).
Subtotal (5/6) nephrectomy
At 8 weeks of age, animals underwent left-sided subcapsular
nephrectomy or sham surgery through a flank incision. One week
later, the upper and lower thirds of the right kidney were resected
and weighed to achieve subtotal (5/6) nephrectomy or a sham
procedure was performed. Renal mass reduction was performed by
surgical resection, rather than ligation of arterial branches to avoid
significant elevations in blood pressure.33
Hindlimb ischemia
Ten weeks after renal mass reduction or sham surgery, all animals
underwent unilateral (left limb) induction of hindlimb ischemia
under anesthesia with medetomidine/ketamine (0.5 and 75 mg/kg,
respectively). Briefly, under aseptic conditions, the common femoral
artery was ligated at the level of the inguinal ligament and excised
down to the branching of the deep femoral artery, which was also
ligated using 5-0 silk sutures (Ethicon, Somerville, NJ, USA).
A sham procedure (preparation of arteries without ligation) was
performed on the contralateral leg. Post-surgery animals received
subcutaneous buprenorphine (0.03 mg/kg twice daily) for pain relief
over 2 days. Animals were killed 2 weeks after surgery and muscles
of both legs were harvested, weighed, and either digested for
microsphere extraction, snap frozen in liquid nitrogen for RNA
isolation, or embedded in Tissue-TekTM (Sakura, Zoeterwoude, The
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Figure 5 | Expression of VEGF and VEGFR-1 and -2 mRNA in non-ischemic and ischemic muscles (reverse transcription-polymerase
chain reaction from M. tibialis anterior). Top panel: Relative copy numbers; bottom panel: relative change of expression in ischemic vs
non-ischemic limbs.
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Netherlands) and frozen in isopentane solution supercooled by
immersion in liquid nitrogen.
Capillary density analysis and histomorphometry
Capillary density of M. gastrocnemius and M. soleus of both non-
ischemic and ischemic hindlimbs was determined in 10 randomly
chosen, non-overlapping fields of 6mm cryostat cross-sections made
through the midbelly of each muscle using a monoclonal anti-rat CD31
antibody (1:300; BD Pharmingen, San Diego, CA, USA) and a
fluorescent-labelled anti-immunoglobulin G secondary antibody
(1:250, donkey anti-mouse 594 nm; Molecular Probes, Eugene, OR,
USA) as described previously.34 Images were taken by use of a digital
camera (Nikon Digital Sight DS-SMc, Japan;  20 objective) that was
connected to a fluorescence microscope (Leica DMR, Wetzlar, Germany).
Capillaries were automatically counted after threshold mapping using
image analysis software (MetaVue Version 4.6r9; Molecular Devices,
Downington, PA, USA). To account for the complexity of capillary
growth in ischemic hindlimbs, we also measured capillary area by
analyzing the percentage of fluorescent pixels within each image, which
was then related to the total number of myocytes, normalized, and
expressed as the percentage of capillary area/100 myocytes.
Myocytes were outlined by use of a polyclonal antibody against
laminin (Chemicon, Temecula, CA, USA) that was probed with a
fluorescent-labelled anti-immunoglobulin G secondary antibody
(1:600, goat anti-rabbit 350 nm; Molecular Probes, Eugene, OR,
USA) and counted manually.
To analyze collateral vessel histomorphology, 6 mm sections made
through the proximal portion of gracilis muscles were stained with
hematoxylin/eosin or probed with CD31 (see above) and a
fluorescein isothiocyanate-conjugated a-smooth muscle actin anti-
body (1:1000; Sigma, St Louis, MO, USA). Intima–media ratios were
calculated using MetaVue.
Laser Doppler hindlimb perfusion
Hindlimb perfusion was measured before surgery, 1 day after surgery,
and on the day of killing (day 14) using a laser Doppler perfusion
imager (LDI2-VR; Moor Instruments, Axminster, UK). All measure-
ments were performed during the morning hours in a quiet,
temperature and light-controlled room after acclimatization of animals
for 20 min. At each time point, two measurements were performed
and averaged. To account for confounding variables, perfusion was
expressed as the ratio of ischemic to non-ischemic hindlimb. Notably,
the laser Doppler perfusion imaging primarily measures superficial
blood flow, that is, skin circulation that does not necessarily reflect
skeletal muscle perfusion. Thus, a 690 nm helium–neon laser is readily
absorbed by blood and skin surface components, thereby limiting its
tissue penetration.35 These limitations prompted us to perform a sham
surgery on the contralateral leg to account for changes in perfusion
related to manipulation during surgery.
Microsphere analysis
To determine hindlimb perfusion, the descending aorta was
cannulated with a pediatric dialysis butterfly needle after the
animals had been killed. Hindquarters were perfused at 100 mm Hg
with phosphate-buffered saline (pH 7.4) containing 0.1 mmol/l
sodium nitroprusside and 10 U/ml heparin. Under maximum
vasodilation, vortexed, and ultrasonicated red fluorescent micro-
spheres (15mm; Molecular Probes, Eugene, OR, USA) were injected
into the perfusion line. To avoid streaming of microspheres that
occurs with bolus injection, fluorescent beads were injected at a
constant rate over a 1 min period.
Enzymatic digestion of thigh adductor muscles and extraction of
microspheres was performed according to the protocol described by
Buschmann et al.36 using a proteinase/sodium dodecyl sulfate
solution. Blue-green fluorescent microspheres (15 mm; Molecular
Probes, Eugene, OR, USA) were added to the digestion solution as
an internal reference standard to achieve a final concentration of
10 000 spheres/ml. Tissue samples were digested over 24 h in a
shaking water bath at 421C. All samples were then centrifuged at
1000 g for 30 min and the pellet was resuspended in CellWash
solution (Becton Dickinson, Lincoln Park, NJ, USA).
Fluorescence was analyzed using a multimode microplate reader
(SpectraFluor, Tecan, Switzerland). To account for autofluorescence,
skeletal muscle of rats that did not undergo hindlimb ischemia or
microsphere injection was digested with or without known amounts
of both red and blue-green fluorescent microspheres. Following 1:1
dilution steps, these samples served as reference samples to obtain a
standard curve. These standards together with blanks were vortexed
and loaded onto 96-well plates (100 ml/well) together with digested
samples from both non-ischemic and ischemic hindlimbs of
treatment groups and emission of fluorescent dyes was analyzed.
Each sample was measured in duplicate and counts were normalized
based on the recovery of blue-green fluorescent spheres. Signals were
related to muscle weight and ischemic hindlimb perfusion was
expressed relative to the non-ischemic limb.
Blood pressure measurements
Before killing, arterial blood pressure was measured in all rats. After
a midline incision in the neck, the right carotid artery was exposed
and cannulated with a polyethylene tubing catheter. The catheter
was secured with sutures and subcutaneously tunnelled to exit at the
back of the neck. The end of the catheter was connected to a
Statham pressure transducer and a Gould polygraph. Blood pressure
was measured in conscious unrestrained rats over 20 min.
Metabolic cages
Before the induction of hindlimb ischemia, all animals were housed
in metabolic cages over 24 h for urine collection. Body weight, food
intake, water consumption, and urine output were monitored.
Proteinuria was measured and expressed as urinary albumin
excretion per gram creatinine.
Blood gases, blood count, and serum chemistry
Blood samples drawn from the arterial catheter were injected into an
arterial blood gas analyzer (Radiometer Copenhagen, Brønshøj,
Denmark). The following parameters were obtained: pH, pO2,
pCO2, oxygen saturation, hemoglobin, hematocrit, sodium, potas-
sium, chloride, bicarbonate, base excess, glucose, and lactate.
Further blood was collected through exsanguination under deep
anesthesia, immediately centrifuged, and stored at 801C until
further processed. The following parameters were measured from
these samples: creatinine, urea, calcium, phosphate, ADMA, VEGF,
and erythropoietin.
ADMA, VEGF, and erythropoietin enzyme-linked
immunosorbent assay
Plasma levels of ADMA, an endogenous inhibitor of NO synthase,
were measured in a blinded manner using an enzyme-linked
immunosorbent assay kit (DLD Diagnostika GmbH, Hamburg,
Germany) as described earlier.24 ADMA is elevated in patients with
renal failure owing to reduced renal clearance.22 Recently, Jacobi
from our group and co-workers24 have shown that this molecule
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impairs angiogenesis and arteriogenesis in a murine hindlimb
ischemia model. Accordingly, we hypothesized that ADMA levels
might be elevated in rats undergoing 5/6 nephrectomy and may
contribute to impaired angioadaptation following hindlimb ische-
mia. Plasma VEGF levels were measured using a commercially
available enzyme-linked immunosorbent assay kit (R&D Systems,
Minneapolis, MN, USA) following the instructions of the manu-
facturer. Serum levels of erythropoietin were measured using a
monoclonal enzyme immunoassay kit (Medac GmbH, Wedel,
Germany). All measurements were performed in duplicate, and
mean values were computed.
Plasma and urinary nitrate/nitrite
Plasma as well as urinary nitrate/nitrite was measured using a
colorimetric assay kit (Cayman Chemicals, Ann Arbor, MI, USA).
Briefly, the assay consists of a two-step process; the first step is the
conversion of nitrate to nitrite utilizing nitrate reductase. The
second step is the addition of the Griess reagents, which converts
nitrite into a deep purple azo compound. Photometric absorbance
was measured at 540 nm. All samples were measured in duplicate
and mean values were computed.
Real-time reverse transcription-polymerase chain reaction
RNA of non-ischemic and ischemic muscle tissue from the
M. tibialis anterior (five animals/group) was isolated to analyze
mRNA expression of VEGF, VEGFR-1 (VEGFR-1/Flt-1), VEGFR-2
(VEGFR-2/Flk-1), NO synthase type II (inducible NO synthase) and
NO synthase type III (endothelial NO synthase). Briefly, RNA was
extracted with TriFast reagent (Peqlab, Erlangen, Germany) by the
method of Chomczynski.37 First-strand cDNA was synthesized with
TaqMan RT reagents (Applied Biosystems, Darmstadt, Germany)
using random hexamers. Polymerase chain reaction was performed
with an ABI PRISM 7000 sequence detector and SYBR green
reagents (Applied Biosystems, Foster City, CA, USA) according to
the manufacturer’s instructions. All samples were run in duplicate.
The relative amount of the specific mRNA of interest was
normalized to 18S rRNA. Dissociation curves were performed to
confirm the specificity of the polymerase chain reaction. Primer
sequences are depicted in Table 3.
Statistical analysis
Statistical analysis was performed by use of SPSS software package
(version 12.0). All data are given as mean7s.e.m. Pearson’s
correlation coefficients were calculated when indicated. Compar-
isons between groups were analyzed by unpaired Student’s t-test or
analysis of variance, and comparisons within groups by paired
Student’s t-test. Statistical significance was accepted at a value of
Po0.05 (two-sided).
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